Accendra Health, Inc. ACH
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 86.89% | 89.75% | 74.11% | 80.98% | -1,076.70% |
| Total Depreciation and Amortization | -39.28% | 52.84% | 43.91% | -29.75% | 4.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 57.54% | -104.88% | 6.40% | -135.42% | -2,189.24% |
| Change in Net Operating Assets | -57.35% | 210.45% | -1,579.80% | 60,275.22% | 203.06% |
| Cash from Operations | 89.91% | -169.15% | -42.81% | -3.96% | -731.78% |
| Capital Expenditure | 7.03% | 17.42% | 9.06% | 73.80% | 26.93% |
| Sale of Property, Plant, and Equipment | -27.45% | -15.55% | 471.04% | 31.78% | 3.56% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 301.27% | 107.74% | 95.62% | -143.29% | -223.35% |
| Cash from Investing | 114.61% | 40.95% | 211.88% | 644.90% | -45.15% |
| Total Debt Issued | -81.66% | 77.78% | -65.37% | -42.06% | 31.21% |
| Total Debt Repaid | 83.15% | -117.21% | 67.98% | 36.38% | 17.30% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -109.69% | -2,520.06% | 87.08% | -352.09% | 8,914.95% |
| Cash from Financing | -83.10% | -958.00% | -44.94% | -172.64% | 190.74% |
| Foreign Exchange rate Adjustments | 102.94% | -100.00% | -107.56% | 109.85% | -103.12% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 161.31% | -1,965.21% | 445.96% | 1,017.31% | 84.41% |